Martingale Asset Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Sell |
20,932
-1,200
| -5% | -$9.04K | ﹤0.01% | 766 |
|
|
2025
Q1 | $168K | Sell |
22,132
-16,413
| -43% | -$124K | ﹤0.01% | 746 |
|
|
2024
Q4 | $469K | Buy |
38,545
+5,703
| +17% | +$69.5K | 0.01% | 617 |
|
|
2024
Q3 | $550K | Buy |
32,842
+18,820
| +134% | +$315K | 0.01% | 610 |
|
|
2024
Q2 | $245K | Sell |
14,022
-28,507
| -67% | -$497K | 0.01% | 726 |
|
|
2024
Q1 | $725K | Hold |
42,529
| – | – | 0.01% | 539 |
|
|
2023
Q4 | $433K | Hold |
42,529
| – | – | 0.01% | 637 |
|
|
2023
Q3 | $385K | Hold |
42,529
| – | – | 0.01% | 648 |
|
|
2023
Q2 | $458K | Hold |
42,529
| – | – | 0.01% | 631 |
|
|
2023
Q1 | $435K | Buy |
42,529
+900
| +2% | +$9.21K | 0.01% | 645 |
|
|
2022
Q4 | $439K | Buy |
41,629
+10,613
| +34% | +$112K | 0.01% | 639 |
|
|
2022
Q3 | $398K | Buy |
+31,016
| New | +$398K | 0.01% | 662 |
|